<DOC>
	<DOCNO>NCT00449722</DOCNO>
	<brief_summary>To proof therapeutic equivalence daily ( OD ) versus three time daily ( TID ) dose total 3.0 g mesalazine granules patient active ulcerative colitis</brief_summary>
	<brief_title>OD vs. TID Dosing With Mesalazine Granules Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Inclusion Criteria ( main ) : Active ulcerative colitis except proctitis , i.e . inflammation minimal 15cm ab ano , confirm endoscopy histology Established new diagnosis Disease activity baseline : Clinical Activity Index ( CAI ) &gt; 4 Endoscopic Index ( EI ) &gt; = 4 Exclusion Criteria ( main ) : Crohn 's disease Toxic megacolon Present past colorectal cancer Symptomatic gastrointestinal disease Serious secondary disease ( ) Baseline stool positive germ cause bowel disease Immunosuppressants within 3 month and/or corticosteroid within 1 month prior baseline Current relapse occur maintenance treatment &gt; 2g/day mesalazine Serum creatinine &gt; = 1.2x upper limit normal ( ULN ) creatinine clearance &lt; 60 ml/min per 1.73 m2 Serum transaminase ( ALT and/or AST ) , and/or alkaline phosphatase &gt; = 2x ULN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>